TELA Bio (TELA) Change in Receivables (2018 - 2026)
TELA Bio (TELA) recorded quarterly Change in Receivables of -$593000.0 in Q1 2026, up 36.37% quarter-over-quarter from -$932000.0 in Q4 2025, and down 247.51% on a YoY basis from $402000.0 in Q1 2025.
TELA Bio (TELA) Change in Receivables (2018 - 2026) Analysis & Trends
TELA Bio's Change in Receivables history runs 9 years deep, the most recent figure standing at -$593000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 247.51% year-over-year to -$593000.0; the TTM figure through Mar 2026 stood at -$885000.0 (down 195.16% YoY), while the FY2025 annual figure was $110000.0, down 85.56% from the prior year.
- Change in Receivables was -$593000.0 for Q1 2026 at TELA Bio, up from -$932000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.0 million in Q3 2024 to a low of -$983000.0 in Q4 2024.
- Historically, Change in Receivables has averaged $338705.9 across 5 years, with a median of $237000.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables soared 1200.0% in 2024, then sank 247.51% in 2026.
- A 5-year view of Change in Receivables shows it stood at $890000.0 in 2022, then jumped by 80.0% to $1.6 million in 2023, then slumped by 161.36% to -$983000.0 in 2024, then climbed by 5.19% to -$932000.0 in 2025, then soared by 36.37% to -$593000.0 in 2026.
- The last three Change in Receivables figures came in at -$593000.0 (Q1 2026), -$932000.0 (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | -593,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -593,000.00 |
| Mar 31, 2026 | -593,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | -497,000.00 |
| Jun 30, 2024 | -497,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |